β-adrenergic blocking agent
Definition: a class of drugs that competes with β-adrenergic agonists for available receptor sites; some compete for both β1 and β2 receptors (propranolol) whereas others are primarily either β1 (metoprolol) or β2 blockers; used in the treatment of a variety of cardiovascular diseases for which β-adrenergic blockade is desirable.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.